AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home Food Science Article
PDF (2.1 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Publishing Language: Chinese | Open Access

Recent Advances in the Research of Milk-Derived Tripeptides with Clinically Confirmed Antihypertensive Effects

Huiqin ZHOU1 , Junxia XIAO1, Qingjun RONG2, Haigang TAN1, Jie SUN3, Guoqing HUANG1 ( )
College of Food Science and Engineering, Qingdao Agricultural University, Qingdao 266109, China
Qingdao Bernia Food Co., Ltd., Qingdao 266109, China
Shandong Peanut Research Institute, Qingdao 266109, China
Show Author Information

Abstract

Hypertension is a major threat to health and food-derived angiotensin-converting enzyme inhibitory peptides (ACEIPs) have been recognized as potential alternatives to synthetic angiotensin-converting enzyme (ACE) inhibitors in the treatment of hypertension due to their high safety and non-toxicity. A large number of antihypertensive peptides with in vitro ACE inhibitory activity have been isolated and identified, but only a few of them including Ile-Pro-Pro (IPP), Val-Pro-Pro (VPP), and Leu-Pro-Pro (LPP) have been confirmed to be clinically effective for humans. Originally isolated from fermented milk, the three peptides are collectively called lactotripeptides. Several antihypertensive functional foods based on lactotripeptides have been marketed in many overseas countries and their efficacy has been fully verified, but such products are yet not available in China. In this context, the functions, safety, production methods, and new sources of the lactotripeptides are reviewed and patents concerning them are summarized herein. This review is expected to provide valuable information for the development of third-generation antihypertensive functional foods in China.

CLC number: TS201.1 Document code: A Article ID: 1002-6630(2022)09-0326-11

References

【1】
【1】
 
 
Food Science
Pages 326-336

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
ZHOU H, XIAO J, RONG Q, et al. Recent Advances in the Research of Milk-Derived Tripeptides with Clinically Confirmed Antihypertensive Effects. Food Science, 2022, 43(9): 326-336. https://doi.org/10.7506/spkx1002-6630-20210223-244

699

Views

0

Downloads

0

Crossref

2

Scopus

3

CSCD

Received: 23 February 2021
Published: 15 May 2022
© Beijing Academy of Food Sciences 2022.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).